Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.
Open Access
- 1 October 1988
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 51 (10) , 1264-1268
- https://doi.org/10.1136/jnnp.51.10.1264
Abstract
Single photon emission computed tomography (SPECT) imaging of six Huntington's disease patients revealed a striking reduction in regional uptake of cerebral blood flow markers in vivo. Similar changes were found in one patient with "early stage" disease. The findings are compared with parallel magnetic resonance imaging (MRI) studies, and in one case, results of postmortem examination.This publication has 15 references indexed in Scilit:
- A low field NMR imager for clinical useJournal of Physics E: Scientific Instruments, 1987
- Differential Diagnosis in Dementia Using the Cerebral Blood Flow Agent 99mTc HM-PAOJournal of Computer Assisted Tomography, 1987
- Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's DiseaseArchives of Neurology, 1987
- Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects.Proceedings of the National Academy of Sciences, 1986
- Clinical brain imaging with isopropyl-iodoamphetamine and SPECTSeminars in Nuclear Medicine, 1985
- Radioactive oxygen-15 in the study of cerebral blood flow, blood volume, and oxygen metabolismSeminars in Nuclear Medicine, 1985
- Bicaudate diameter?the most specific and simple CT parameter in the diagnosis of Huntington's diseaseNeuroradiology, 1984
- Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scanAnnals of Neurology, 1982
- Morphometric studies of the neuropathological changes in choreatic diseasesJournal of the Neurological Sciences, 1976
- Pneumoencephalographic findings in Huntington's choreaNeurology, 1968